HOOK
Price
$1.24
Change
-$0.02 (-1.59%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
15.24M
QURE
Price
$14.22
Change
-$0.11 (-0.77%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
779.07M
35 days until earnings call
Interact to see
Advertisement

HOOK vs QURE

Header iconHOOK vs QURE Comparison
Open Charts HOOK vs QUREBanner chart's image
HOOKIPA Pharma
Price$1.24
Change-$0.02 (-1.59%)
Volume$226
Capitalization15.24M
uniQure
Price$14.22
Change-$0.11 (-0.77%)
Volume$22.86K
Capitalization779.07M
HOOK vs QURE Comparison Chart in %
Loading...
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HOOK vs. QURE commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HOOK is a Hold and QURE is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (HOOK: $1.26 vs. QURE: $14.33)
Brand notoriety: HOOK and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HOOK: 20% vs. QURE: 49%
Market capitalization -- HOOK: $15.24M vs. QURE: $779.07M
HOOK [@Biotechnology] is valued at $15.24M. QURE’s [@Biotechnology] market capitalization is $779.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HOOK’s FA Score shows that 1 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • HOOK’s FA Score: 1 green, 4 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, HOOK is a better buy in the long-term than QURE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HOOK’s TA Score shows that 2 TA indicator(s) are bullish while QURE’s TA Score has 4 bullish TA indicator(s).

  • HOOK’s TA Score: 2 bullish, 6 bearish.
  • QURE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, QURE is a better buy in the short-term than HOOK.

Price Growth

HOOK (@Biotechnology) experienced а -3.45% price change this week, while QURE (@Biotechnology) price change was -5.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +32.55%, and the average quarterly price growth was +15.13%.

Reported Earning Dates

HOOK is expected to report earnings on May 15, 2025.

QURE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($779M) has a higher market cap than HOOK($15.2M). QURE YTD gains are higher at: -18.856 vs. HOOK (-37.313). HOOK has higher annual earnings (EBITDA): -70.92M vs. QURE (-138.01M). QURE has more cash in the bank: 409M vs. HOOK (40.3M). HOOK has less debt than QURE: HOOK (596K) vs QURE (66.2M). QURE has higher revenues than HOOK: QURE (20.2M) vs HOOK (9.35M).
HOOKQUREHOOK / QURE
Capitalization15.2M779M2%
EBITDA-70.92M-138.01M51%
Gain YTD-37.313-18.856198%
P/E RatioN/AN/A-
Revenue9.35M20.2M46%
Total Cash40.3M409M10%
Total Debt596K66.2M1%
FUNDAMENTALS RATINGS
HOOK vs QURE: Fundamental Ratings
HOOK
QURE
OUTLOOK RATING
1..100
5254
VALUATION
overvalued / fair valued / undervalued
1..100
12
Undervalued
79
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6540
P/E GROWTH RATING
1..100
10092
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOOK's Valuation (12) in the Pharmaceuticals Major industry is significantly better than the same rating for QURE (79) in the Biotechnology industry. This means that HOOK’s stock grew significantly faster than QURE’s over the last 12 months.

HOOK's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as QURE (100) in the Biotechnology industry. This means that HOOK’s stock grew similarly to QURE’s over the last 12 months.

HOOK's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as QURE (100) in the Biotechnology industry. This means that HOOK’s stock grew similarly to QURE’s over the last 12 months.

QURE's Price Growth Rating (40) in the Biotechnology industry is in the same range as HOOK (65) in the Pharmaceuticals Major industry. This means that QURE’s stock grew similarly to HOOK’s over the last 12 months.

QURE's P/E Growth Rating (92) in the Biotechnology industry is in the same range as HOOK (100) in the Pharmaceuticals Major industry. This means that QURE’s stock grew similarly to HOOK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HOOKQURE
RSI
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
HOOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MERDX34.52N/A
N/A
Meridian Growth Legacy
SASMX35.16N/A
N/A
ClearBridge Small Cap Growth A
SCICX46.54N/A
N/A
Columbia Seligman Tech & Info C
NAWGX50.26N/A
N/A
Voya Global High Dividend Low Vol A
CFGIX19.18N/A
N/A
Cromwell Foresight Glbl Sust InfrasInstl